We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Free Web-Based Application Designed to Streamline Medical Image Interpretation

By MedImaging International staff writers
Posted on 11 Feb 2014
Print article
A web-based tool created by researchers enables physicians and researchers to better interpret the huge amount of information contained in medical images by gathering data in a way that is precise and computationally accessible.

The tool, called the electronic Physician Annotation Device (ePAD), was developed by the Stanford University (Stanford, CA, USA) Rubin Lab at the School of Medicine and is available to download free of charge. Daniel Rubin, MD, an assistant professor of radiology, and his team initially designed ePAD in response to an unmet need in cancer imaging, but he says the tool can be used more generally quantitatively evaluate images and characterize disease. He said, “Currently, images are recorded in narrative text form. However, a narrative is a very muddy picture if a clinician and/or patient is trying to understand how the picture has changed over time and determine the response of a disease treatment. But if a radiologist is looking at images and all the data from earlier studies, such as dates and abnormalities, is contained in a table and a graph shows the changes in time, then it is easier for referring clinicians to understand and for computers to process.”

The other distinctive feature is that ePAD runs in a web browser. The advantage of doing this is the platform can be run anywhere, without needing to install software locally, or require a costly workstation, such as uses in radiology departments.

Dr. Rubin is currently in the process of establishing a pilot project of the system at the Stanford Cancer Institute. As part of the project, ePAD will be used to assess treatment success for patients who are matched to clinical trials using a smart database. Clinicians and researchers at other institutions have also begun using the tool, and Dr. Rubin has plans to increase its reach to create a huge, searchable medical image database. “We’re very excited about ePAD because we think it has far reaching implications,” he said.

Users, after downloading the platform, can utilize its graphic interface to review images, record semantic annotations, and make measurements. Information is stored in compliance with standards developed by the US National Cancer Institute’s Annotation and Image Markup (AIM), so that physicians can use the application to access other related imaging studies even if they were not interpreted using ePAD. Furthermore, annotations can be saved in a variety of formats so content can be simply and automatically searched across medical records systems, hospital image archives and the Semantic Web.

Related Links:

Stanford University


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Portable Radiology System
DRAGON ELITE & CLASSIC
Ultrasound Doppler System
Doppler BT-200
New
Ultrasound System
P20 Elite

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.